It was a busy week as normal for tech stocks. Microsoft made a bold move, Intel shares slumped, and Amazon is jumping into the booming IoT industry. Fool analysts Nathan Hamilton and Sean O'Reilly discuss each news event and what it means for shareholders.

Today’s Industry Focus is talking Exxon, Chevron, and how not to fall prey to silly journalism in the energy space.

MannKind and Orexigen: two companies with big promise, but can they deliver on profit? Healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the risks facing these biotech stocks.

Are shares of Chipotle copy-cats becoming overvalued? Tune in to find out.

Initial bank stress tests results are out, and analysts discuss their importance and potential implications of this Wednesday’s round two results.

The tech world was focused on one event this past week – The Mobile World Congress. Held in Spain, the event serves as barometer of tech trends in coming years. Fool analysts Nathan Hamilton and Sean O’Reilly sit down to discuss the event and what it means for investors.

Healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the pitfalls and potential of two small cap biotech stocks.

Motley Fool analysts Sean O’Reilly and Vincent Shen discuss the global gaming industry and opportunities for investors.

Fool contributor John Maxfield takes on a few key points from this year’s letter to Berkshire Hathaway shareholders.

A lot has been said about the concerns and potential capabilities of AI. But how close is AI is to becoming reality? It may be farther out on the horizon than some believe.